{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:13Z","timestamp":1792511953076,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015436","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000}}],"reference-count":201,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015436.pub2","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T17:37:44Z","timestamp":1765388264000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic factors associated with progression of open-angle glaucoma in adults"],"prefix":"10.1002","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0236-0101","authenticated-orcid":false,"given":"Mapa Prabhath","family":"Piyasena","sequence":"additional","affiliation":[{"name":"Vision and Eye Research Institute; Faculty of Health, Medicine and Social Care, School of Medicine, Anglia Ruskin University; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q\u00ebndres\u00eb","family":"Daka","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology; Medical Faculty, University of Prishtina \"Hasan Prishtina\"; Prishtin\u00eb Kosovo"},{"name":"Eye Clinic; University Clinical Centre of Kosova; Prishtin\u00eb Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz; Aurora Colorado USA"},{"name":"Department of Epidemiology; Colorado School of Public Health; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Roberti","sequence":"additional","affiliation":[{"name":"IRCCS-Fondazione Bietti; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuele","family":"Michelessi","sequence":"additional","affiliation":[{"name":"IRCCS-Fondazione Bietti; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz; Aurora Colorado USA"},{"name":"Department of Epidemiology; Colorado School of Public Health; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz; Aurora Colorado USA"},{"name":"Department of Epidemiology; Colorado School of Public Health; Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemisi","family":"Takwoingi","sequence":"additional","affiliation":[{"name":"Department of Applied Health Sciences; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Azuara-Blanco","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Institute of Clinical Sciences Block A, Queen's University Belfast; Belfast - Northern Ireland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[{"name":"IRCCS-Fondazione Bietti; Rome Italy"},{"name":"NEUROFARBA; University of Florence; Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"supported by the Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Global Health"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1167\/iovs.18-25922","article-title":"Association of gene polymorphisms with primary open angle glaucoma: a systematic review and meta-analysis","volume":"60","author":"Chen","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00061198-199400320-00018","article-title":"Exfoliation syndrome \u2014 the most common identifiable cause of open-angle glaucoma","volume":"3","author":"Ritch","year":"1994","journal-title":"Journal of Glaucoma"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/OPTH.S181444","article-title":"Monitoring and management of the patient with pseudoexfoliation syndrome: current perspectives","volume":"13","author":"Tekin","year":"2019","journal-title":"Clinical Ophthalmology (Auckland, N.Z.)"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Progress in Retinal and Eye Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015436.pub2-BIB0007|cit7","first-page":"1","article-title":"European Glaucoma Society terminology and guidelines for glaucoma, 5th edition","volume":"105","author":"European Glaucoma Society","year":"2021","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"Conlon","year":"2017","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in Glaucoma and ocular Hypertension (LiGHT) Trial: Six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamaophthalmol.2021.2351","article-title":"Minimally invasive glaucoma surgical techniques for open angle glaucoma: an overview of Cochrane systematic reviews and network meta-analysis","volume":"139","author":"Bicket","year":"2021","journal-title":"JAMA Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0161-6420(00)00263-3","article-title":"Non-penetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma","volume":"107","author":"El Sayyad","year":"2000","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"British Journal of Ophthalmology"},{"issue":"19","key":"10.1002\/14651858.CD015436.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.2013.5099","article-title":"Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review","volume":"309","author":"Hollands","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e5595","DOI":"10.1136\/bmj.e5595","article-title":"Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes","volume":"346","author":"Hemingway","year":"2013","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12874-020-01050-7","article-title":"A conceptual framework for prognostic research","volume":"20","author":"Kent","year":"2020","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis research strategy (PROGRESS) 2: prognostic factor research","volume":"10","author":"Riley","year":"2013","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognostic research strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1167\/iovs.06-0299","article-title":"Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis","volume":"47","author":"Rudnicka","year":"2006","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.62.2.28","article-title":"The role of genetic ancestry as a risk factor for primary open-angle glaucoma in African Americans","volume":"62","author":"Cole","year":"2021","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.optom.2016.02.003","article-title":"Glaucoma history and risk factors","volume":"10","author":"McMonnies","year":"2017","journal-title":"Journal of Optometry"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archopht.1995.01100020100038","article-title":"Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment","volume":"113","author":"Tielsch","year":"1995","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0024|cit24","volume-title":"Glaucoma: The Requisites in Ophthalmology","author":"Alward","year":"2000"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ophtha.2011.03.012","article-title":"Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis","volume":"118","author":"Marcus","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"Advanced Glaucoma Intervention Study (AGIS) Investigators","year":"2000","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"9975","key":"10.1002\/14651858.CD015436.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1038\/s41598-020-66914-w","article-title":"Ocular perfusion pressure and the risk of open-angle glaucoma: systematic review and meta-analysis","volume":"10","author":"Kim","year":"2020","journal-title":"Scientific Reports"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/ajh\/hpv016","article-title":"Circadian variation in arterial blood pressure and glaucomatous optic neuropathy \u2014 a systematic review and meta-analysis","volume":"28","author":"Bowe","year":"2015","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2019.02.015","article-title":"Predictive factors for the rate of visual field progression","volume":"202","author":"Zhang","year":"2019","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ophtha.2012.09.005","article-title":"An evidence-based review of prognostic factors for glaucomatous visual field progression","volume":"120","author":"Ernest","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ophtha.2020.06.009","article-title":"Risk factors for visual field deterioration in the United Kingdom Glaucoma Treatment Study","volume":"127","author":"Founti","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12886-016-0264-7","article-title":"Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey","volume":"16","author":"Kyari","year":"2016","journal-title":"BMC Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/bjophthalmol-2019-315052","article-title":"Progression from ocular hypertension to visual field loss in the English hospital eye service","volume":"104","author":"Kelly","year":"2020","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/09286586.2016.1193207","article-title":"Risk factors associated with progression to blindness from primary open-angle glaucoma in an African-American population","volume":"23","author":"Pleet","year":"2016","journal-title":"Ophthalmic Epidemiology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2019.06.019","article-title":"Risk factors for fast visual field progression in glaucoma","volume":"207","author":"Kim","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.06.003","article-title":"Risk factors for rapid glaucoma disease progression","volume":"180","author":"Chan","year":"2017","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/iovs.61.8.35","article-title":"Risk factors associated with structural progression in normal-tension glaucoma: intraocular pressure, systemic blood pressure, and myopia","volume":"61","author":"Lee","year":"2020","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1755-3768.2009.01595.x","article-title":"Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma","volume":"88","author":"Mart\u00ednez","year":"2010","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12931-020-01533-7","article-title":"Obstructive sleep apnea as a risk factor for primary open angle glaucoma and ocular hypertension in a monocentric pilot study","volume":"21","author":"Bahr","year":"2020","journal-title":"Respiratory Research"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"e0239529","DOI":"10.1371\/journal.pone.0239529","article-title":"Fasting plasma glucose level and the risk of open angle glaucoma: nationwide population-based cohort study in Korea","volume":"15","author":"Choi","year":"2020","journal-title":"PloS One"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/07315724.2019.1691952","article-title":"The role of nutrition in primary open angle glaucoma: a multivariate analysis","volume":"39","author":"Mylona","year":"2020","journal-title":"Journal of the American College of Nutrition"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"e19285","DOI":"10.1097\/MD.0000000000019285","article-title":"Underweight increases the risk of primary open-angle glaucoma in diabetes patients: a Korean nationwide cohort study","volume":"99","author":"Na","year":"2020","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2018.07.011","article-title":"Macular damage, as determined by structure-function staging, is associated with worse vision-related quality of life in early glaucoma","volume":"194","author":"Garg","year":"2018","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.11-7900","article-title":"A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients","volume":"53","author":"De Moraes","year":"2012","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e615\u201320","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma \u2014 ProgF study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2019.06.020","article-title":"Prediction of glaucoma progression with structural parameters: comparison of optical coherence tomography and clinical disc parameters","volume":"208","author":"Daneshvar","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0051|cit51","unstructured":"National Institute of Health and Care Excellence\u00a0 Glaucoma: diagnosis and management. NICE guideline [NG81] nice.org.uk\/guidance\/ng81"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"k4597","DOI":"10.1136\/bmj.k4597","article-title":"A guide to systematic review and meta-analysis of prognostic factor studies","volume":"364","author":"Riley","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0053|cit53","unstructured":"Covidence Veritas Health Innovation"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0055|cit55","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41512-019-0050-0","article-title":"Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS \u2014 aspects of interrater agreement","volume":"3","author":"Wilhelmus","year":"2019","journal-title":"Diagnostic and Prognostic Research"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jrsm.1266","article-title":"Detecting small study effects and funnel plot asymmetry in meta-analysis survival data: a comparison of new and existing tests","volume":"9","author":"Debray","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinepi.2019.12.023","article-title":"GRADE Guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks","volume":"121","author":"Foroutan","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/OPX.0000000000001519","article-title":"Longitudinal evaluation of the structural and functional changes associated with glaucoma in myopia","volume":"97","author":"Biswas","year":"2020","journal-title":"Optometry and Vision Science"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1030-6","DOI":"10.1001\/archopht.126.8.1030","article-title":"Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma","volume":"126","author":"Chauhan","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archophthalmol.2010.196","article-title":"Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change","volume":"128","author":"Chauhan","year":"2010","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2015.11.031","article-title":"Neuroretinal rim area change in glaucoma patients with visual field progression endpoints and intraocular pressure reduction. The Canadian Glaucoma Study: 4","volume":"163","author":"Malik","year":"2016","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0065|cit65","first-page":"566-75","article-title":"Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses","volume":"41","author":"Canadian Glaucoma Study Group","year":"2006","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archopht.126.8.1138","article-title":"Finding risks for glaucoma","volume":"126","author":"Brandt","year":"2008","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0067|cit67","unstructured":"The Canadian glaucoma study clinicaltrials.gov\/study\/NCT00262626"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3892\/etm.2021.9714","article-title":"Association between vascular comorbidity and glaucoma progression: a four-year observational study","volume":"21","author":"Dascalu","year":"2021","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17116\/oftalma202213805157","article-title":"Choroidal microvascular dropout as a biomarker of glaucoma progression in patients with diabetes mellitus","volume":"138","author":"Fursova","year":"2022","journal-title":"Vestnik Oftalmologii"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.03-1274","article-title":"Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss","volume":"45","author":"Jonas","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.ijg.0000212209.25642.01","article-title":"Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage","volume":"15","author":"Jonas","year":"2006","journal-title":"Journal of Glaucoma"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0161-6420(02)01098-9","article-title":"Small neuroretinal rim and large parapapillary atrophy as predictive factors for progression of glaucomatous optic neuropathy","volume":"109","author":"Jonas","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD015436.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/sj.eye.6702351","article-title":"Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma","volume":"21","author":"Jonas","year":"2007","journal-title":"Eye (London, England)"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ajo.2004.12.056","article-title":"Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma","volume":"139","author":"Martus","year":"2005","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0075|cit75","first-page":"646","article-title":"Enlargement of parapapillary atrophy in follow-up of chronic open-angle glaucoma","volume":"137","author":"Budde","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.11.10.24","article-title":"Predictive modeling of long-term glaucoma progression based on initial ophthalmic data and optic nerve head characteristics","volume":"11","author":"Lee","year":"2022","journal-title":"Translational Vision Science and Technology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/IJG.0000000000002275","article-title":"Association between optic disc perfusion determined by swept-source optical coherence tomography angiography and visual field progression in glaucoma","volume":"32","author":"Lee","year":"2023","journal-title":"Journal of Glaucoma"},{"issue":"7","key":"10.1002\/14651858.CD015436.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ophtha.2009.02.003","article-title":"Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study","volume":"116","author":"Leung","year":"2009","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bjo.2009.175992","article-title":"Pressure-cornea-vascular index (PCVI) for predicting disease progression in normal tension glaucoma","volume":"95","author":"Leung","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ophtha.2009.08.016","article-title":"Simvastatin and disease stabilization in normal tension glaucoma: a cohort study","volume":"117","author":"Leung","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2022.09.015","article-title":"Risk of normal tension glaucoma progression from automated baseline retinal-vessel caliber analysis: a prospective cohort study","volume":"247","author":"Lin","year":"2023","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ophtha.2008.12.062","article-title":"The relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma","volume":"116","author":"Medeiros","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ophtha.2009.08.012","article-title":"Agreement for detecting glaucoma progression with the GDx guided progression analysis, automated perimetry, and optic disc photography","volume":"117","author":"Alencar","year":"2010","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2016.07.023","article-title":"Optical coherence tomography angiography vessel density in glaucomatous eyes with focal lamina cribrosa defects","volume":"123","author":"Suh","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1167\/iovs.09-3715","article-title":"Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements","volume":"50","author":"Medeiros","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD015436.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1167\/iovs.09-4350","article-title":"A comparison of rates of change in neuroretinal rim area and retinal nerve fiber layer thickness in progressive glaucoma","volume":"51","author":"Alencar","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1167\/iovs.13-13246","article-title":"Detecting glaucoma progression from localized rates of retinal changes in parametric and nonparametric statistical framework with type I error control","volume":"55","author":"Balasubramanian","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ajo.2007.07.042","article-title":"Reproducibility of visual field end point criteria for standard automated perimetry, full-threshold, and Swedish interactive thresholding algorithm strategies: diagnostic innovations in glaucoma study","volume":"144","author":"Bourne","year":"2007","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajo.2020.06.012","article-title":"Capillary density measured by optical coherence tomography angiography in glaucomatous optic disc phenotypes","volume":"219","author":"Ekici","year":"2020","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/IJG.0000000000002081","article-title":"Effects of smoking on optic nerve head microvasculature density in glaucoma","volume":"31","author":"Eslani","year":"2022","journal-title":"Journal of Glaucoma"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ajo.2007.01.046","article-title":"Intereye spatial relationship of abnormal neuroretinal rim locations in glaucoma patients from the diagnostic innovations in glaucoma study","volume":"143","author":"Hoffmann","year":"2007","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajo.2018.03.026","article-title":"Inter-eye asymmetry of optical coherence tomography angiography vessel density in bilateral glaucoma, glaucoma suspect, and healthy eyes","volume":"190","author":"Hou","year":"2018","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.11.018","article-title":"Multilayer macula vessel density and visual field progression in glaucoma","volume":"237","author":"Kamalipour","year":"2022","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ophtha.2006.09.015","article-title":"Retinal nerve fiber layer damage as assessed by optical coherence tomography in eyes with a visual field defect detected by frequency doubling technology perimetry but not by standard automated perimetry","volume":"114","author":"Kim","year":"2007","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1167\/iovs.09-4716","article-title":"Effect of disease severity on the performance of Cirrus spectral-domain OCT for glaucoma diagnosis","volume":"51","author":"Leite","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjophthalmol-2020-318065","article-title":"Association of foveal avascular zone area with structural and functional progression in glaucoma patients","volume":"106","author":"Li","year":"2022","journal-title":"British Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.ophtha.2010.02.015","article-title":"The relationship between intraocular pressure reduction and rates of progressive visual field loss in eyes with optic disc hemorrhage","volume":"117","author":"Medeiros","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2009.01.021","article-title":"Impact of atypical retardation patterns on detection of glaucoma progression using the GDx with variable corneal compensation","volume":"148","author":"Medeiros","year":"2009","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.123.10.1351","article-title":"Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma","volume":"123","author":"Medeiros","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2007.08.012","article-title":"Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma","volume":"115","author":"Medeiros","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31820bd1fd","article-title":"Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change","volume":"21","author":"Medeiros","year":"2012","journal-title":"Journal of Glaucoma"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ogla.2020.07.005","article-title":"Comparison of peripapillary capillary density in glaucoma patients of African and European descent","volume":"4","author":"Moghimi","year":"2021","journal-title":"Ophthalmology Glaucoma"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajo.2004.05.072","article-title":"Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss","volume":"138","author":"Mohammadi","year":"2004","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0104|cit104","unstructured":"Diagnostic innovations in glaucoma study clinicaltrials.gov\/study\/NCT00221897"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jamaophthalmol.2021.1812","article-title":"Estimated utility of the short-term assessment of glaucoma progression model in clinical practice","volume":"139","author":"Proudfoot","year":"2021","journal-title":"JAMA Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1167\/iovs.07-0493","article-title":"Diagnostic accuracy of the Matrix 24-2 and original N-30 frequency-doubling technology tests compared with standard automated perimetry","volume":"49","author":"Racette","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2017.07.011","article-title":"Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study","volume":"182","author":"Shoji","year":"2017","journal-title":"American Journal of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.ophtha.2016.09.002","article-title":"Deep retinal layer microvasculature dropout detected by the optical coherence tomography angiography in glaucoma","volume":"123","author":"Suh","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2019.07.023","article-title":"Corneal biomechanics and visual field progression in eyes with seemingly well-controlled intraocular pressure","volume":"126","author":"Susanna","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1167\/iovs.13-12921","article-title":"Estimation of retinal ganglion cell loss in glaucomatous eyes with a relative afferent pupillary defect","volume":"55","author":"Tatham","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ophtha.2013.12.015","article-title":"Detecting glaucoma using automated pupillography","volume":"121","author":"Tatham","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"OCT451","DOI":"10.1167\/iovs.15-18944","article-title":"Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes","volume":"57","author":"Yarmohammadi","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD015436.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/IJG.0000000000002236","article-title":"Association between longitudinal 10-2 central visual field change and the risk of visual acuity loss in mild-to-moderate glaucoma","volume":"32","author":"Wu","year":"2023","journal-title":"Journal of Glaucoma"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajo.2023.08.007","article-title":"Relationship of choroidal microvasculature dropout and beta-zone parapapillary area with visual field changes in glaucoma","volume":"257","author":"Latif","year":"2024","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/bjo-2022-321237","article-title":"Smoking and progressive retinal nerve fibre layer thinning in glaucoma","volume":"107","author":"Nishida","year":"2023","journal-title":"British Journal of Ophthalmology"},{"issue":"14","key":"10.1002\/14651858.CD015436.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1167\/iovs.19-27984","article-title":"Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the Groningen Longitudinal Glaucoma study","volume":"60","author":"Pappelis","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0000000000002138","article-title":"Baseline 10-2 visual field loss as a predictor for future glaucoma progression","volume":"32","author":"Sullivan-Mee","year":"2023","journal-title":"Journal of Glaucoma"},{"issue":"7","key":"10.1002\/14651858.CD015436.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1111\/aos.15117","article-title":"Optical coherence tomography angiography metrics predict normal tension glaucoma progression","volume":"100","author":"Wang","year":"2022","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0119|cit119","first-page":"365","article-title":"Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies","volume":"100","author":"Wilson","year":"2002","journal-title":"Transactions of the American Ophthalmological Society"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/OPTH.S146455","article-title":"Long-term progression of visual field defects and related factors in medically treated normal tension glaucoma","volume":"12","author":"Yoshikawa","year":"2018","journal-title":"Clinical Ophthalmology (Auckland, N.Z.)"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2016.02.017","article-title":"Risk of visual field progression in glaucoma patients with progressive retinal nerve fiber layer thinning: a 5-year prospective study","volume":"123","author":"Yu","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2017.12.027","article-title":"Integrating macular ganglion cell inner plexiform layer and parapapillary retinal nerve fiber layer measurements to detect glaucoma progression","volume":"125","author":"Hou","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"94-103","DOI":"10.1016\/j.ajo.2016.09.015","article-title":"Baseline fourier-domain optical coherence tomography structural risk factors for visual field progression in the Advanced Imaging for Glaucoma Study","volume":"172","author":"Zhang","year":"2016","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0124|cit124","unstructured":"Advanced Imaging for Glaucoma Study (AIGS) clinicaltrials.gov\/study\/NCT01314326"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1642-51","DOI":"10.1016\/j.ophtha.2020.06.009","article-title":"Risk factors for visual field deterioration in the United Kingdom Glaucoma Treatment study","volume":"127","author":"Founti","year":"2020","journal-title":"Ophthalmology"},{"issue":"9975","key":"10.1002\/14651858.CD015436.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1295-304","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2018.09.034","article-title":"Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials? : evidence from the United Kingdom Glaucoma Treatment study","volume":"126","author":"Jones","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0128|cit128","first-page":"2250","article-title":"Clinically relevant artefactual intraocular pressure lowering resulting from corneal biomechanical changes under latanoprost treatment: data from the UKGTS","volume":"60","author":"Munoa","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"295-304","DOI":"10.1016\/j.ogla.2020.10.008","article-title":"OCT signal enhancement with deep learning","volume":"4","author":"Lazaridis","year":"2021","journal-title":"Ophthalmology Glaucoma"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/opo.12378","article-title":"Using perimetric data to estimate ganglion cell loss for detecting progression of glaucoma: a comparison of models","volume":"37","author":"Price","year":"2017","journal-title":"Ophthalmic & Physiological Optics"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"2540-5","DOI":"10.1016\/j.ophtha.2013.07.054","article-title":"The United Kingdom Glaucoma Treatment study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics","volume":"120","author":"Lascaratos","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0132|cit132","first-page":"2464","article-title":"Risk factors for glaucoma progression in the United Kingdom Glaucoma Treatment Study (UKGTS)","volume":"58","author":"Founti","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"15","key":"10.1002\/14651858.CD015436.pub2-BIB0133|cit133","first-page":"2619","article-title":"The United Kingdom Glaucoma Treatment study (UKGTS): baseline characteristics and main outcomes","volume":"54","author":"Lascaratos","year":"2013","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"68-76","DOI":"10.1016\/j.ophtha.2012.07.028","article-title":"The United Kingdom Glaucoma Treatment study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology","volume":"120","author":"Garway-Heath","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"460-5","DOI":"10.1016\/j.ophtha.2006.06.056","article-title":"Visual field and intraocular pressure asymmetry in the Low-pressure Glaucoma Treatment study","volume":"114","author":"Greenfield","year":"2007","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1002\/14651858.CD015436.pub2-BIB0136|cit136","first-page":"3577","article-title":"Visual field asymmetry is unrelated to intraocular pressure asymmetry in the Low-pressure Glaucoma Treatment study","volume":"46","author":"Greenfield","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"945-52","DOI":"10.1016\/j.ajo.2014.02.009","article-title":"Risk factors for optic disc hemorrhage in the Low-pressure Glaucoma Treatment study","volume":"157","author":"Furlanetto","year":"2014","journal-title":"American Journal of Ophthalmology"},{"issue":"13","key":"10.1002\/14651858.CD015436.pub2-BIB0138|cit138","first-page":"1304","article-title":"Baseline intraocular pressure, visual function, and disc hemorrhage in the Low-pressure Glaucoma Treatment study","volume":"46","author":"Liebmann","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"376-85","DOI":"10.1016\/j.ophtha.2004.10.034","article-title":"The Low-pressure Glaucoma Treatment study (LoGTS) study design and baseline characteristics of enrolled patients","volume":"112","author":"Krupin","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"702-11","DOI":"10.1016\/j.ajo.2012.04.015","article-title":"Risk factors for visual field progression in the Low-pressure Glaucoma Treatment study","volume":"154","author":"De Moraes","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"13","key":"10.1002\/14651858.CD015436.pub2-BIB0141|cit141","first-page":"5634","article-title":"Reliability indices and rates of visual field change in glaucoma","volume":"55","author":"De Moraes","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9394(14)73754-7","article-title":"The Glaucoma Laser Trial (GLT): 6. Treatment group differences in visual field changes","volume":"120","author":"Glaucoma Laser Trial Research Group","year":"1995","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0143|cit143","first-page":"1403","article-title":"The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines","volume":"97","author":"Glaucoma Laser Trial Research Group","year":"1990","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9394(14)72725-4","article-title":"The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial follow-up study: 7. Results","volume":"120","author":"Glaucoma Laser Trial Research Group","year":"1995","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0197-2456(91)90010-J","article-title":"The Glaucoma Laser Tial (GLT): 3. Design and methods","volume":"12","author":"Glaucoma Laser Trial Research Group","year":"1991","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0146|cit146","first-page":"3761","article-title":"Contribution of each treatment session to IOP reduction resulting from split therapy alt in the Glaucoma Laser Trial (GLT)","volume":"35","author":"Wilensky","year":"1994","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0147|cit147","first-page":"1187","article-title":"Optic disc characteristics of blacks and whites in the Glaucoma Laser Trial (GLT)","volume":"35","author":"Kiri","year":"1994","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/clm.1991.9.103","article-title":"Glaucoma Laser trial Reports encouraging early results","volume":"9","author":"Karpen","year":"1991","journal-title":"Journal of Clinical Laser Medicine & Surgery"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1965-72","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the Early Manifest Glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"48-56","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"281-7","DOI":"10.1111\/aos.13290","article-title":"Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial","volume":"95","author":"\u00d6hnell","year":"2017","journal-title":"Acta Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1173-80","DOI":"10.1016\/j.ophtha.2016.01.039","article-title":"Structural and functional progression in the Early Manifest Glaucoma trial","volume":"123","author":"\u00d6hnell","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00132578-200310000-00007","article-title":"Factors for glaucoma progression and the effect of treatment","volume":"4","author":"Leske","year":"2003","journal-title":"Evidence-Based Eye Care"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00132578-200307000-00009","article-title":"Reduction of intraocular pressure and glaucoma progression","volume":"4","author":"Heijl","year":"2003","journal-title":"Evidence-Based Eye Care"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"2044-8","DOI":"10.1016\/j.ophtha.2008.05.031","article-title":"Disc hemorrhages and treatment in the Early Manifest Glaucoma Trial","volume":"115","author":"Bengtsson","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1268-79","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015436.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"2144-53","DOI":"10.1016\/S0161-6420(99)90497-9","article-title":"Early Manifest Glaucoma trial: design and baseline data","volume":"106","author":"Leske","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"842-8","DOI":"10.1016\/j.ajo.2011.04.036","article-title":"Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma trial","volume":"152","author":"Heijl","year":"2011","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"749-54","DOI":"10.1111\/j.1755-3768.2009.01852.x","article-title":"Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma trial","volume":"89","author":"Heijl","year":"2011","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"745-52","DOI":"10.1111\/aos.12839","article-title":"Visual impairment and vision-related quality of life in the Early Manifest Glaucoma trial after 20 years of follow-up","volume":"93","author":"Peters","year":"2015","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0161|cit161","unstructured":"Early Manifest Glaucoma trial (EMGT) clinicaltrials.gov\/study\/NCT00000132"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0162|cit162","first-page":"2990","article-title":"The Early Manifest Glaucoma trial: study aims and design","volume":"40","author":"Heijl","year":"1999","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0163|cit163","first-page":"926","article-title":"The Early Manifest Glaucoma trial: baseline results","volume":"40","author":"Leske","year":"1999","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"859-64","DOI":"10.1097\/IJG.0000000000001342","article-title":"Making a correct diagnosis of glaucoma: data from the EMGT","volume":"28","author":"\u00d6hnell","year":"2019","journal-title":"Journal of Glaucoma"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"205-9","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"2271-6","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1505-13","DOI":"10.1016\/j.ophtha.2005.03.028","article-title":"Treatment and vision-related quality of life in the Early Manifest Glaucoma trial","volume":"112","author":"Hyman","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajo.2023.04.010","article-title":"Long-term impact of immediate versus delayed treatment of early glaucoma: results from the Early Manifest Glaucoma trial","volume":"252","author":"Heijl","year":"2023","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015436.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2020.03.029","article-title":"Visual field outcomes from the multicenter, randomized controlled Laser in Glaucoma and ocular Hypertension Trial (LiGHT)","volume":"127","author":"Wright","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1238-48","DOI":"10.1016\/j.ophtha.2019.04.012","article-title":"Primary selective laser trabeculoplasty for open-angle glaucoma and ocular hypertension: clinical outcomes, predictors of success, and safety from the laser in Glaucoma and Ocular Hypertension trial","volume":"126","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD015436.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"467-76","DOI":"10.1016\/j.ophtha.2019.10.023","article-title":"Efficacy of repeat selective laser trabeculoplasty in medication-naive open-angle glaucoma and ocular hypertension during the LiGHT trial","volume":"127","author":"Garg","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0172|cit172","first-page":"20-1","article-title":"Lessons from the United Kingdom Glaucoma Treatment study (UKGTS) and Laser in Glaucoma and ocular Hypertension (LiGHT) study synopsis","volume":"47","author":"Garway-Heath","year":"2019","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"593-8","DOI":"10.1136\/bjophthalmol-2017-310877","article-title":"Laser in Glaucoma and ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology","volume":"102","author":"Gazzard","year":"2018","journal-title":"British Journal of Ophthalmology"},{"issue":"31","key":"10.1002\/14651858.CD015436.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1-102","DOI":"10.3310\/hta23310","article-title":"Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT","volume":"23","author":"Gazzard","year":"2019","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"599-603","DOI":"10.1136\/bjophthalmol-2017-310870","article-title":"The Laser in Glaucoma and ocular Hypertension (LiGHT) Trial. A multicentre randomised controlled trial: baseline patient characteristics","volume":"102","author":"Konstantakopoulou","year":"2018","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bjophthalmol-2021-320128","article-title":"Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort","volume":"107","author":"Yang","year":"2022","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0177|cit177","first-page":"694","article-title":"Laser in Glaucoma and ocular Hypertension Trial (LiGHT) in China \u2014 an unmasked, pragmatic randomized controlled trial: design and baseline characteristics","volume":"60","author":"Yang","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s13063-015-1047-9","article-title":"Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial","volume":"16","author":"Vickerstaff","year":"2015","journal-title":"Trials"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0179|cit179","first-page":"5574","article-title":"LiGHT: Laser in Glaucoma and ocular Hypertension Trial \u2014 methodology and baseline characteristics of a multicentre randomised controlled trial","volume":"58","author":"Gazzard","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD015436.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in Glaucoma and ocular Hypertension (LiGHT) Trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/bjophthalmol-2021-320968","article-title":"Validation of the RCOphth and UKEGS glaucoma risk stratification tool 'GLAUC-STRAT-fast'","volume":"107","author":"Konstantakopoulou","year":"2023","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0182|cit182","unstructured":"Laser-1st vs drops-1st for glaucoma and ocular hypertension (LIGHT) clinicaltrials.gov\/study\/NCT03395535"},{"issue":"10180","key":"10.1002\/14651858.CD015436.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1505-16","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Risk factors for progression of visual field abnormalities in normal-tension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD015436.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"P454","DOI":"10.1016\/j.ogla.2021.01.007","article-title":"What do we really know about the effectiveness of glaucoma interventions?","volume":"4","author":"Qureshi","year":"2021","journal-title":"Ophthalmology Glaucoma"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"e000032","DOI":"10.1136\/bmjophth-2016-000032","article-title":"Retinal vasculature in glaucoma: a review","volume":"1","author":"Chan","year":"2017","journal-title":"BMJ Open Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3341\/kjo.2015.29.1.40","article-title":"Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucoma","volume":"29","author":"Jeong","year":"2015","journal-title":"Korean Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ajh\/hpad111","article-title":"The relevance of arterial blood pressure in the management of glaucoma progression: a systematic review","volume":"37","author":"Eijgen","year":"2024","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1016\/j.ajo.2023.03.014","article-title":"A systematic review and meta-analysis of systemic antihypertensive medications with intra-ocular pressure and glaucoma","volume":"255","author":"Leung","year":"2023","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ophtha.2020.06.067","article-title":"Cardiovascular disease predicts structural and functional progression in early glaucoma","volume":"128","author":"Marshall","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0191|cit191","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s42452-020-03221-z","article-title":"A review on the optic disc and optic cup segmentation and classification approaches over retinal fundus images for detection of glaucoma","volume":"2","author":"Veena","year":"2020","journal-title":"AN Applied Sciences"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/jcm9030761","article-title":"Primary open angle glaucoma and vascular risk factors: a review of population-based studies from 1990 to 2019","volume":"9","author":"Grzybowski","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0193|cit193","first-page":"2419","article-title":"Association of diabetes, fasting glucose and the risk of glaucoma: a systematic review and meta-analysis","volume":"27","author":"AlDarrab","year":"2023","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD015436.pub2-BIB0194|cit194","first-page":"1783","article-title":"The relationship between central corneal thickness and intraocular pressure in healthy and glaucomatous eyes: a systematic review and meta-analysis","volume":"12","author":"Lungowe","year":"2016","journal-title":"International Eye Science"},{"issue":"3","key":"10.1002\/14651858.CD015436.pub2-BIB0195|cit195","first-page":"293","article-title":"Trace element exposure and risk in age-related eye diseases: a systematic review of epidemiological evidence","volume":"39","author":"Bede-Ojimadu","year":"2021","journal-title":"Journal of Environmental Science and Health"},{"issue":"12","key":"10.1002\/14651858.CD015436.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"e0166915","DOI":"10.1371\/journal.pone.0166915","article-title":"Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis","volume":"11","author":"D'Azy","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/14651858.CD015436.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00417-023-06103-3","article-title":"Ocular manifestations of obstructive sleep apnea: a systematic review and meta-analysis","volume":"262","author":"Bulloch","year":"2024","journal-title":"Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie [Graefe's Archive for Clinical and Experimental Ophthalmology]"},{"issue":"8","key":"10.1002\/14651858.CD015436.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.3390\/ijms23084226","article-title":"Vitamin D and ocular diseases: a systematic review","volume":"23","author":"Chan","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1177\/11206721231168146","article-title":"VEGF levels in the aqueous humor of patients with primary open angle glaucoma: a systematic review and meta-analysis","volume":"33","author":"Dimtsas","year":"2023","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015436.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/microorganisms8060894","article-title":"Association between active helicobacter pylori infection and glaucoma: a systematic review and meta-analysis","volume":"8","author":"Dulberis","year":"2020","journal-title":"Microorganisms"},{"issue":"9","key":"10.1002\/14651858.CD015436.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.63.9.17","article-title":"Ambient air pollution and age-related eye disease: a systematic review and meta-analysis","volume":"63","author":"Grant","year":"2022","journal-title":"Investigative Ophthalmology & Visual Science"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:05:22Z","timestamp":1792368322000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015436.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":201,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015436.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}